Literature DB >> 4467179

The effects of penicillamine on lymphocytes in culture.

S Roath, R Wills.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4467179

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  8 in total

1.  Concomitant immune-related events in Wilson disease: implications for monitoring chelator therapy.

Authors:  Jessica Seessle; Daniel Nils Gotthardt; Mark Schäfer; Annina Gohdes; Jan Pfeiffenberger; Peter Ferenci; Wolfgang Stremmel; Karl Heinz Weiss
Journal:  J Inherit Metab Dis       Date:  2015-06-12       Impact factor: 4.982

2.  D-penicillamine: mitogenic effect on mouse, rat and human spleen lymphocytes.

Authors:  M H Claësson; G S Hansen; V Tjell
Journal:  Med Microbiol Immunol       Date:  1979-08       Impact factor: 3.402

Review 3.  Induction of auto-immune syndromes by penicillamine therapy in rheumatoid arthritis and other diseases.

Authors:  I A Jaffe
Journal:  Springer Semin Immunopathol       Date:  1981

4.  The effect of D-penicillamine on polymorphonuclear leukocyte function.

Authors:  H Chwalinska-Sadowska; J Baum
Journal:  J Clin Invest       Date:  1976-10       Impact factor: 14.808

5.  Investigations on the influence of cyclophosphamide, gold sodium thiomalate and D-penicillamine on nystatin oedema and adjuvant arthritis.

Authors:  E Arrigoni-Martelld; E Bramm
Journal:  Agents Actions       Date:  1975-08

6.  The influence of prolonged treatment with D-penicillamine on the immune response in Wilson's disease.

Authors:  A Czlonkowska
Journal:  Eur J Clin Pharmacol       Date:  1977-12-02       Impact factor: 2.953

7.  The effect of thiol compounds on lymphocytes stimulated in culture.

Authors:  P A Kendall; D Hutchins
Journal:  Immunology       Date:  1978-07       Impact factor: 7.397

8.  Historical perspectives on penicillamine.

Authors:  L Fernandes; H Berry; E Hamilton
Journal:  J R Coll Physicians Lond       Date:  1980-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.